Vincent Haghnejad

Statistics

Publications

Citations

H-Index

Active since

2019

Affiliations

Université de Lorraine(Current)

Inserm

Vincent Haghnejad is an author at Université de Lorraine specializing in inflammatory bowel disease therapy, inflammatory bowel disease care, and clinical sciences.

ORCID

Publications per year

2019–2022

Publications

Inflammatory Bowel Disease Patients’ Acceptance for Switching from Intravenous Infliximab or Vedolizumab to Subcutaneous Formulation: The Nancy Experience

C. Remy, Bénédicte Caron, Célia Gouynou et al. · Journal of Clinical Medicine · 2022 · 28 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +16

Impact of a medical interview on the decision to switch from originator infliximab to its biosimilar in patients with inflammatory bowel disease

Vincent Haghnejad, Catherine Le Berre, Yoann Dominique et al. · Digestive and Liver Disease · 2019 · 24 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

1–2 of 2